<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">44288</article-id><article-id pub-id-type="doi">10.7554/eLife.44288</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-127218"><name><surname>Kabir</surname><given-names>Shaheen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-129197"><name><surname>Cidado</surname><given-names>Justin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-129198"><name><surname>Andersen</surname><given-names>Courtney</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2064-2273</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-129199"><name><surname>Dick</surname><given-names>Cortni</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-129200"><name><surname>Lin</surname><given-names>Pei-Chun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-129201"><name><surname>Mitros</surname><given-names>Therese</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-129202"><name><surname>Ma</surname><given-names>Hong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-129203"><name><surname>Baik</surname><given-names>Seung Hyun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-129204"><name><surname>Belmonte</surname><given-names>Matthew A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-129205"><name><surname>Drew</surname><given-names>Lisa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" corresp="yes" id="author-49456"><name><surname>Corn</surname><given-names>Jacob E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7798-5309</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Innovative Genomics Institute</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">IMED Oncology</institution>, <institution>AstraZeneca</institution>, <addr-line><named-content content-type="city">Waltham</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">IMED Oncology</institution>, <institution>AstraZeneca</institution>, <addr-line><named-content content-type="city">Waltham</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1519"><name><surname>Green</surname><given-names>Michael R</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, University of Massachusetts Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jacob.corn@biol.ethz.ch</email> (JC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>11</day><month>07</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e44288</elocation-id><history><date date-type="received"><day>15</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>05</day><month>07</month><year>2019</year></date></history><permissions><copyright-statement>Â© 2019, Kabir et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Kabir et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-44288-v1.pdf"/><abstract><p>Overexpression of anti-apoptotic proteins MCL1 and Bcl-xL are frequently observed in many cancers. Inhibitors targeting MCL1 are in clinical development, however numerous cancer models are intrinsically resistant to this approach. To discover mechanisms underlying resistance to MCL1 inhibition, we performed multiple flow-cytometry based genome-wide CRISPR screens interrogating two drugs that directly (MCL1i) or indirectly (CDK9i) target MCL1. Remarkably, both screens identified three components (CUL5, RNF7 and UBE2F) of a cullin-RING ubiquitin ligase complex (CRL5) that resensitized cells to MCL1 inhibition. We find that levels of the BH3-only pro-apoptotic proteins Bim and Noxa are proteasomally regulated by the CRL5 complex. Accumulation of Noxa caused by depletion of CRL5 components was responsible for re-sensitization to CDK9 inhibitor, but not MCL1 inhibitor. Discovery of a novel role of CRL5 in apoptosis and resistance to multiple types of anti-cancer agents suggests the potential to improve combination treatments.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004325</institution-id><institution>AstraZeneca</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kabir</surname><given-names>Shaheen</given-names></name><name><surname>Cidado</surname><given-names>Justin</given-names></name><name><surname>Andersen</surname><given-names>Courtney</given-names></name><name><surname>Dick</surname><given-names>Cortni</given-names></name><name><surname>Lin</surname><given-names>Pei-Chun</given-names></name><name><surname>Ma</surname><given-names>Hong</given-names></name><name><surname>Belmonte</surname><given-names>Matthew A</given-names></name><name><surname>Drew</surname><given-names>Lisa</given-names></name><name><surname>Corn</surname><given-names>Jacob E</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DP2 HL141006</award-id><principal-award-recipient><name><surname>Corn</surname><given-names>Jacob E</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007421</institution-id><institution>Li Ka Shing Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Corn</surname><given-names>Jacob E</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Heritage Medical Research Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Corn</surname><given-names>Jacob E</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000900</institution-id><institution>California Institute for Regenerative Medicine</institution></institution-wrap></funding-source><award-id>DISC1-08776</award-id><principal-award-recipient><name><surname>Kabir</surname><given-names>Shaheen</given-names></name><name><surname>Baik</surname><given-names>Seung Hyun</given-names></name><name><surname>Corn</surname><given-names>Jacob E</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Justin Cidado, employed by AstraZeneca, from whom funded research support was received..</p></fn><fn fn-type="conflict" id="conf3"><p>Courtney Andersen, employed by AstraZeneca, from whom funded research support was received..</p></fn><fn fn-type="conflict" id="conf4"><p>Cortni Dick, employed by AstraZeneca, from whom funded research support was received..</p></fn><fn fn-type="conflict" id="conf5"><p>Matthew A Belmonte, employed by AstraZeneca, from whom funded research support was received..</p></fn><fn fn-type="conflict" id="conf6"><p>Lisa Drew, employed by AstraZeneca, from whom funded research support was received..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data is being deposited into SRA under accession code: SUB5033643</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kabir S</collab></person-group><year iso-8601-date="2019">2019</year><source>Genome-wide CRISPRi Resensitization Screens with MCL1 Inhibitors</source><ext-link ext-link-type="uri" xlink:href="https://submit.ncbi.nlm.nih.gov/subs/sra/SUB5033643">https://submit.ncbi.nlm.nih.gov/subs/sra/SUB5033643</ext-link><comment>NCBI Sequence Read Archive, SUB5033643</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-44288-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>